AZN R&D Expenses
AstraZeneca PLC Ordinary Shares · R&D Expenses
AZN R&D Expenses
Latest reported$15.07Bperiod ending
AZN R&D Expenses ($704.06M → $15.07B)
Annual R&D Expenses
High-resolution chart · PNG
AZN r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 14,232,000,000 | |
| 13,583,000,000 | |
| 10,935,000,000 | |
| 9,762,000,000 | |
| 9,736,000,000 | |
| 5,991,000,000 | |
| 6,059,000,000 | |
| 5,932,000,000 | |
| 5,757,000,000 | |
| 5,890,000,000 | |
| 5,997,000,000 | |
| 5,579,000,000 | |
| 4,821,000,000 | |
| 5,243,000,000 | |
| 5,523,000,000 | |
| 5,318,000,000 | |
| 4,409,000,000 | |
| 5,179,000,000 | |
| 5,162,000,000 | |
| 3,902,000,000 | |
| 3,379,000,000 | |
| 3,467,000,000 | |
| 3,012,000,000 | |
| 3,069,000,000 | |
| 2,687,000,000 | |
| 2,894,611,064 | |
| 2,472,000,000 | |
| 2,103,000,000 | |
| 1,079,481,584 | |
| 1,030,927,835 | |
| 848,321,898 | |
| 809,843,190 | |
| 767,706,052 | |
| 676,444,269 | |
| 703,566,483 | |
| 704,062,343 |